Quinolines and derivatives
Apexbio Technology LLC Coenzyme Q10 303-98-0 200mg
Coenzyme Q10 (CAS 303-98-0) is a lipophilic benzoquinone involved in mitochondrial electron transport and cellular energy production It functions as an essential electron carrier within the electron transport chain facilitating ATP synthesis and exhibiting antioxidant properties by mitigating oxidative damage Coenzyme Q10 is frequently studied for its role in cellular metabolism bioenergetics and redox homeostasis Due to its involvement in mitochondrial function it is widely applied in research on metabolic disorders neurodegeneration and cardiovascular diseases The compound is soluble in organic solvents such as chloroform benzene and carbon tetrachloride For optimal stability it should be stored sealed in cool and dry conditions
Apexbio Technology LLC AM095 1345614-59-6 200mg
AM095 (CAS 1345614-59-6) is an orally bioavailable antagonist targeting the lysophosphatidic acid receptor 1 (LPA1) It selectively inhibits recombinant human and mouse LPA1 receptors with IC50 values of 0 98 M and 0 73 M respectively In cell-based assays AM095 suppresses LPA1-mediated chemotaxis in mouse LPA1/CHO and human melanoma A2058 cells (IC50 values 0 78 M and 0 23 M respectively) In vivo studies demonstrate its ability to prevent LPA-triggered histamine release reduce collagen and protein accumulation and limit inflammatory cell infiltration in mouse pulmonary models AM095 serves as a valuable tool for investigating LPA1-associated pathologies
Apexbio Technology LLC AM-095 free base 1228690-36-5 200mg
AM-095 free base (CAS 1228690-36-5) is an orally bioavailable antagonist of lysophosphatidic acid receptor 1 (LPA1) It demonstrates inhibitory activity against recombinant human and mouse LPA1 with IC50 values of 0 98 M and 0 73 M respectively In vitro AM-095 suppresses LPA1-mediated chemotaxis in both mouse LPA1/CHO cells (IC50 0 78 M) and human A2058 melanoma cells (IC50 0 23 M) In murine models it blocks LPA-induced histamine release and reduces collagen and protein levels in bronchoalveolar lavage fluid with ED50 values of 8 3 mg/kg and 10 mg/kg respectively Additionally AM-095 decreases macrophage and lymphocyte infiltration in bleomycin-induced lung injury models supporting its utility in studies of LPA1-mediated fibrotic and inflammatory processes
Apexbio Technology LLC Penicillin V potassium salt 132-98-9 200mg
Penicillin V potassium salt (132-98-9) is a small-molecule inhibitor targeting bacterial cell wall peptidoglycan synthesis It is designed to inhibit this biosynthetic pathway thereby suppressing the growth of Gram-positive bacteria Penicillin V potassium salt exerts its biological activity primarily through inhibition of bacterial cell wall synthesis In microbial susceptibility assays Penicillin V potassium salt demonstrates inhibitory effects with IC50 values ranging from approximately 0 01 to 0 5 g/mL for sensitive bacterial strains Based on these pharmacological properties Penicillin V potassium salt holds research potential in studies investigating Gram-positive bacterial resistance mechanisms cell-wall targeting antibiotic actions and experimental models of upper respiratory tract infections including otitis media sinusitis pharyngitis and tonsillitis